-
-
公开(公告)号:EP4410986A2
公开(公告)日:2024-08-07
申请号:EP24178098.0
申请日:2018-07-05
申请人: Kymab Limited
IPC分类号: C12N15/85
CPC分类号: A01K67/0276 , A01K67/0278 , C07K2317/9220130101 , A01K67/027 , C07K16/00 , A01K2217/07220130101 , A01K2217/07520130101 , A01K2217/1520130101 , A01K2227/10520130101 , A01K2267/0120130101 , C07K2317/2120130101 , C07K2317/2420130101 , C07K2317/3120130101 , C07K2317/51520130101 , C07K2317/5520130101 , C07K2317/1420130101
摘要: The invention relates to cells and non-human vertebrates for producing antibody chains (eg, truly common L or H chains), in particular for use in producing multi-specific antibodies useful for therapy or diagnosis.
-
公开(公告)号:EP4015538A1
公开(公告)日:2022-06-22
申请号:EP21204339.2
申请日:2019-12-20
申请人: Kymab Limited
摘要: Bispecific antigen binding molecules (e.g., antibodies) that bind blood clotting factors, factor IXa (FIXa) and factor X (FX), and enhance the FIXa-catalysed activation of FX to FXa. Use of the bispecific antigen binding molecules to control bleeding, by replacing natural cofactor FVIIIa which is deficient in patients with haemophilia A.
-
公开(公告)号:EP3648587A2
公开(公告)日:2020-05-13
申请号:EP18743421.2
申请日:2018-07-05
申请人: Kymab Limited
IPC分类号: A01K67/027 , C12N15/85
-
-
-